Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica Therapeutics

Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins,...

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd.,...

Merz Therapeutics, as part of the Merz Group and a leader in the field of neurotoxins,...

Merz Therapeutics GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA,...

Merz, a global leader in neurotoxin therapy, announced today the European approval of XEOMIN^® (incobotulinumtoxinA)...